Literature DB >> 27142018

Cross-Presentation Assay for Human Dendritic Cells.

Elodie Segura1.   

Abstract

The presentation of exogenous antigens on major histocompatibility complex (MHC) class I molecules, termed cross-presentation, is essential for the initiation of cytotoxic immune responses. Numerous studies in mice and human have shown that dendritic cells are the best cross-presenting cells. The protocol described here allows the assessment of the cross-presentation by human dendritic cells of a model antigen (either soluble or cell associated) to antigen-specific CD8 T cells.

Entities:  

Keywords:  Antigen processing; CD8 T cells; Cross-presentation; Dendritic cells; Human

Mesh:

Year:  2016        PMID: 27142018     DOI: 10.1007/978-1-4939-3606-9_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer.

Authors:  Iwona Kwiecień; Elżbieta Rutkowska; Agata Raniszewska; Piotr Rzepecki; Joanna Domagała-Kulawik
Journal:  World J Clin Oncol       Date:  2021-11-24

Review 2.  Refining the DC-targeting vaccination for preventing emerging infectious diseases.

Authors:  Yadira Pastor; Nour Ghazzaui; Adele Hammoudi; Mireille Centlivre; Sylvain Cardinaud; Yves Levy
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

3.  Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway.

Authors:  Tsing-Lee Tang-Huau; Paul Gueguen; Christel Goudot; Mélanie Durand; Mylène Bohec; Sylvain Baulande; Benoit Pasquier; Sebastian Amigorena; Elodie Segura
Journal:  Nat Commun       Date:  2018-07-02       Impact factor: 14.919

Review 4.  A guide to measuring phagosomal dynamics.

Authors:  Roni Levin-Konigsberg; Adriana R Mantegazza
Journal:  FEBS J       Date:  2020-08-16       Impact factor: 5.542

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.